Single-cell Omics Market to Grow at a CAGR of 6.87% through 2029F
Growing
biotechnology & biopharmaceutical industries and advances in single-cell
technologies is expected to drive the Global Single-cell Omics Market growth in
the forecast period, 2025-2029.
According
to TechSci Research report, “Single-cell Omics Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029F”,
the Global Single-cell Omics Market stood at USD 1.42 billion in
2023 and is anticipated to project steady growth in the forecast period with a
CAGR of 6.87% through
2029. The Global Single-cell Omics Market is being propelled by the increasing
demand for personalized medicine and the growing emphasis on understanding the
complexity of diseases at a single-cell resolution. In cancer research,
single-cell omics is revolutionizing our understanding of tumor heterogeneity,
clonal evolution, and therapeutic resistance mechanisms. Single-cell profiling
of tumor cells, immune cells, and stromal components enables the characterization
of intra-tumoral heterogeneity, identification of rare cell populations, and
discovery of novel therapeutic targets for precision oncology interventions.
Single-cell omics is playing a pivotal role in unraveling the complexity of the
nervous system and embryonic development. By profiling individual neuronal
cells and progenitors, researchers can elucidate cell type diversity, lineage
trajectories, and gene regulatory networks underlying neurodevelopmental
disorders and brain diseases. Similarly, in developmental biology, single-cell
analysis facilitates the study of cell fate determination, tissue
morphogenesis, and organogenesis, offering insights into embryonic development
and regenerative medicine.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Single-cell Omics Market”
Single-cell
omics is transforming the understanding of immune responses, infectious
diseases, and host-pathogen interactions. By profiling immune cells at the
single-cell level, researchers can dissect immune cell diversity, functional
states, and dynamic responses to pathogens and vaccines. Single-cell
analysis of microbial pathogens and host cells provides insights into pathogen
virulence, immune evasion strategies, and host-pathogen interactions, informing
the development of novel vaccines and therapeutics for infectious diseases.
The
Global Single-cell Omics Market is segmented into product type, application,
end user, regional distribution, and company.
In
2023, the Single-cell Omics market experienced dominance by academic and
research organizations, a trend poised to persist in the foreseeable future.
These institutions, renowned for their pioneering research and innovative
endeavors, have been at the forefront of advancing single-cell omics
technologies and applications. With a relentless pursuit of scientific
discovery and a commitment to pushing the boundaries of knowledge, academic and
research organizations have propelled the adoption and expansion of single-cell
omics across diverse fields, including genomics, transcriptomics, and
proteomics.
The
dominance of academic and research organizations in the Single-cell Omics
market reflects their unparalleled expertise, infrastructure, and collaborative
networks, which are instrumental in driving technological advancements and
translating scientific insights into tangible outcomes. The
increasing collaboration between academia, industry, and government agencies
further amplifies the impact of academic research on market growth and
innovation. As the demand for high-resolution, single-cell analysis continues
to soar, fueled by the quest for precision medicine and deeper understanding of
biological complexity, academic and research organizations are expected to
maintain their leadership position, shaping the future trajectory of the
Single-cell Omics market through groundbreaking discoveries and transformative
applications.
In the forecast period, the oncology
segment is anticipated to dominate the Single-cell Omics market based on
application. This dominance is attributed to the critical role of single-cell
omics in revolutionizing cancer research and precision oncology. Single-cell
analysis enables the comprehensive characterization of intra-tumoral
heterogeneity, identification of rare cell populations, and elucidation of
tumor evolution and resistance mechanisms.
The oncology segment's dominance is
further fueled by the urgent need for personalized cancer therapies tailored to
individual patients' molecular profiles. Single-cell omics facilitates the
discovery of novel therapeutic targets, prediction of treatment responses, and
development of targeted therapies, thereby driving advancements in precision
oncology.
The increasing adoption of
single-cell omics in clinical oncology settings for liquid biopsy, minimal
residual disease monitoring, and companion diagnostics further propels the
growth of the oncology segment in the Single-cell Omics market. As cancer
remains a global healthcare challenge, the oncology segment is poised to
maintain its dominance, shaping the future of single-cell omics in cancer
research and clinical practice.
In the forecast period, North America is
anticipated to dominate the global Single-cell Omics market. This dominance is
attributed to several factors, including the presence of a robust healthcare
infrastructure, technological advancements, and significant investments in
research and development. The region boasts a high concentration of
leading biotechnology and pharmaceutical companies, academic institutions, and
research organizations, driving innovation and adoption of single-cell omics technologies. Favorable regulatory frameworks and supportive government
initiatives further contribute to North America's prominence in the Single-cell
Omics market. With a strong emphasis on precision medicine and personalized
healthcare, North America is poised to maintain its leadership position,
shaping the future landscape of single-cell omics on a global scale.
Major
companies operating in Global Single-cell Omics Market are:
- Danaher Corporation
- CYTENA GmbH
- 10x Genomics Inc
- Becton, Dickinson and
Company
- Cellenion SASU
- PerkinElmer Inc.
- ANGLE plc
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Mission Bio, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“The
future of the Single-cell Omics market appears promising, primed for
significant growth as it becomes increasingly central to personalized medicine
and complex biological research. Advancements in genomics, transcriptomics, and
epigenomics are expected to drive innovation, providing deeper insights into
cellular behaviors and intercellular interactions. This growth will likely be
fueled by increased R&D investments, technological breakthroughs in
single-cell analysis, and a rising demand for targeted disease treatments. As
the precision medicine field expands, single-cell technologies will play a
critical role in identifying new therapeutic targets and understanding the
heterogeneity of diseases at a resolution previously unattainable.,” said Mr.
Karan Chechi, Research Director, TechSci Research, a research-based management
consulting firm.
“Single-cell Omics Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product
Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell
Proteomics, Single-Cell Metabolomics), By Application (Oncology, Cell Biology,
Neurology, Immunology), By End-User (Pharmaceutical & Biotechnology
Companies, Academic and Research Organizations, Hospital and Diagnostic
Laboratories, Others), By Region and Competition, 2019-2029F”,
has evaluated the future growth potential of Global Single-cell Omics Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Single-cell Omics Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com